The 16-slice CT scanner is expected to appeal to facilities due to a more affordable price point, Siemens said.
The United States Food and Drug Administration (FDA) has approved the SOMATOM Scope, Siemens’ new 16-slice CT scanner.
The SOMATOM Scope is expected to appeal to facilities looking to extend routine diagnostic imaging services to more patients and in more specialty settings largely because of its price point, a release said. Siemens claims that the SOMATOM Scope delivers image quality, dose reduction, and workflow-enhancing benefits “long associated” with the SOMATOM family of CT scanners.
The SOMATOM Scope includes eCockpit technology, which Siemens explains, extends the scanner’s operational lifetime by minimizing wear and tear on the most vital components of the machine. The SOMATOM Scope was designed for facilities large and small and veterinary medicine. The SOMATOM Scope comes in two configurations, which enables providers to comply with the NEMA XR-29 Smart Dose Standard and ensures a safer imaging experience for patients, a release said.
The SOMATOM Scope Power, the more robust scanner, features a stronger X-ray tube, higher performance generator, and faster rotation speeds, making it ideal for higher volume clinical settings, a release said. The SOMATOM Scope utilizes Siemens’ iterative reconstruction in image space (IRIS) technology, which Siemens claims accelerates image reconstruction while reducing noise and artifacts. The SOMATOM Scope also includes Siemens’ fully assisting scanner technology (FAST) and combined applications to reduce exposure (CARE) applications that help reduce radiation exposure and standardize the CT imaging process, Siemens said.
[[{"type":"media","view_mode":"media_crop","fid":"27860","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_155778324697","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2765","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 1px; border-style: solid; line-height: 1.538em; height: 147px; width: 200px; float: right;","title":"Siemens' SOMATOM Scope CT Scanner","typeof":"foaf:Image"}}]]
Siemens lauds the energy saving aspects of the SOMATOM Scope, which include low heat emissions, a low space requirement of about 130 square feet, and an eSleep mode, which puts the gantry into eSleep mode during periods of extended inactivity.
“By adding the Scope to our portfolio of SOMATOM CT scanners, we help bring CT imaging closer to the point of care, enabling our customers to focus on what matters the most: improving care through more informed, timely clinical decision-making,” Murat Gungor, vice president, computed tomography and radiation oncology business management at Siemens Healthcare, said in a release. “The SOMATOM Scope helps to ensure that a greater segment of the patient population has access to innovative technologies while enabling facilities to help control costs as well as save time and effort throughout their daily routine.”
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.